AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
9.67
-0.29 (-2.91%)
At close: Jul 19, 2024, 4:00 PM
9.59
-0.08 (-0.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

AVITA Medical Revenue

AVITA Medical had revenue of $51.50M in the twelve months ending March 31, 2024, with 27.03% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $11.10M. In the year 2023, AVITA Medical had annual revenue of $51.57M with 37.03% growth.

Revenue (ttm)
$51.50M
Revenue Growth
+27.03%
P/S Ratio
4.84
Revenue / Employee
$248,783
Employees
207
Market Cap
249.48M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.57M13.94M37.03%
Dec 31, 202237.64M3.02M8.73%
Dec 31, 202134.62M16.43M90.31%
Jun 30, 202018.19M6.79M59.62%
Jun 30, 201911.40M2.73M31.54%
Jun 30, 20188.66M3.53M68.74%
Jun 30, 20175.13M3.33M184.18%
Jun 30, 20161.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AirSculpt Technologies 197.72M
Codexis 74.23M
Utah Medical Products 49.04M
Nanobiotix 40.23M
Zevra Therapeutics 28.01M
Senseonics Holdings 23.30M
Profound Medical 5.33M
Immutep 4.58M
Revenue Rankings